The T cell in Sjogren's syndrome: Force majeure, not spectateur

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 229-233

  Singh, Namrata ^a   Cohen, Philip L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Lymphokines; Salivary gland; Th1 cells; Th17 cells; Th2 cells

Indexed keywords

ANTIGEN; AUTOANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 21; LA ANTIGEN; PERFORIN; RO ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; APOPTOSIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CYTOTOXICITY; HELPER CELL; HUMAN; IMMUNOGLOBULIN PRODUCTION; INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; PERFORIN; SALIVARY GLANDS; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 84865389381     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.019     Document Type: Review

References (50)

1. Youinou P. Sjogren's syndrome: a quintessential B cell-induced autoimmune disease. Jt Bone Spine 2008, 75:1-2.
2. Fox R.I., Adamson T.C., Fong S., Young C., Howell F.V. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome. Diagn Immunol 1983, 1:233-239.
3. Adamson T.C., Fox R.I., Frisman D.M., Howell F.V. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 1983, 130:203-208.
4. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun; 34:400-407.
5. Mitsias D.I., Tzioufas A.G., Veiopoulou C., Zintzaras E., Tassios I.K., Kogopoulou O., et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol 2002, 128:562-568.
6. Boumba D., Skopouli F.N., Moutsopoulos H.M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. Br J Rheumatol 1995, 34:326-333.
7. Roescher N., Tak P.P., Illei G.G. Cytokines in Sjogren's syndrome. Oral Dis 2009, 15:519-526.
8. Amft N., Bowman S.J. Chemokines and cell trafficking in Sjogren's syndrome. Scand J Immunol 2001, 54:62-69.
9. Cohen P.L. Stopping traffic in Sjogren's syndrome. Arthritis Rheum 2006, 54:1061-1062.
10. Kang EH, Lee YJ, Hyon JY, Yun PY, Song YW. Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin Exp Rheumatol; 29:970-976.
11. Bertorello R., Cordone M.P., Contini P., Rossi P., Indiveri F., Puppo F., et al. Increased levels of interleukin-10 in saliva of Sjogren's syndrome patients. Correlation with disease activity. Clin Exp Med 2004, 4:148-151.
12. Youinou P., Pers J.O. Disturbance of cytokine networks in Sjogren's syndrome. Arthritis Res Ther 2010, 13:227.
13. Ciccia F., Guggino G., Rizzo A., Ferrante A., Raimondo S., Giardina A., et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 2012, 71:295-301.
14. Katsifis G.E., Rekka S., Moutsopoulos N.M., Pillemer S., Wahl S.M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 2009, 175:1167-1177.
15. Kang G.S., Kim S.H., Bunin V., Shin M.S., Lee N., Parke A., et al. Altered Th17 and Th1 cells reponses in patients with primary Sjogren syndrome. J Immunol 2012, 188:59. 10 (abst).
16. Eriksson P., Andersson C., Ekerfelt C., Ernerudh J., Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren's syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 2004, 137:617-620.
17. Ruan Q, Kameswaran V, Zhang Y, Zheng S, Sun J, Wang J, et al. The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J Exp Med; 208:2321-2333.
18. Waite J.C., Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012, 819467.
19. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007, 282:34605-34610.
20. Kang KY, Kim HO, Kwok SK, Ju JH, Park KS, Sun DI, et al. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther; 13:R179.
21. Li X.Y., Wu Z.B., Ding J., Zheng Z.H., Chen L.N., Zhu P. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren's syndrome. Biochem Biophys Res Commun 2012.
22. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2010, 29:621-663.
23. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos N.M., Moutsopoulos H.M. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008, 173:1389-1396.
24. Sarigul M., Yazisiz V., Bassorgun C.I., Ulker M., Avci A.B., Erbasan F., et al. The numbers of Foxp3+ Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. Lupus 2007, 19:138-145.
25. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
26. Davies M.L., Taylor E.J., Gordon C., Young S.P., Welsh K., Bunce M., et al. Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum 2002, 46:209-214.
27. Reynolds P., Gordon T.P., Purcell A.W., Jackson D.C., McCluskey J. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J Exp Med 1996, 184:1857-1870.
28. Farris A.D., Brown L., Reynolds P., Harley J.B., James J.A., Scofield R.H., et al. Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B). J Immunol 1999, 162:3079-3087.
29. Scofield R.H., Kaufman K.M., Baber U., James J.A., Harley J.B., Kurien B.T. Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum 1999, 42:1017-1024.
30. Scofield R.H., Asfa S., Obeso D., Jonsson R., Kurien B.T. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome. J Immunol 2005, 175:8409-8414.
31. Dudek N.L., Maier S., Chen Z.J., Mudd P.A., Mannering S.I., Jackson D.C., et al. T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201. Arthritis Rheum 2007, 56:3387-3398.
32. Haneji N., Nakamura T., Takio K., Yanagi K., Higashiyama H., Saito I., et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997, 276:604-607.
33. Nagaraju K., Cox A., Casciola-Rosen L., Rosen A. Novel fragments of the Sjogren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum 2001, 44:2376-2386.
34. Mariette X. Sjogren's syndrome and virus. Ann Med Interne (Paris) 1995, 146:243-246.
35. Littman D.R., Pamer E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011, 10:311-323.
36. Niederkorn J.Y., Stern M.E., Pflugfelder S.C., De Paiva C.S., Corrales R.M., Gao J., et al. Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol 2006, 176:3950-3957.
37. Zhang X., Chen W., De Paiva C.S., Volpe E.A., Gandhi N.B., Farley W.J., et al. Desiccating stress induces CD4+ T cell-mediated Sjogren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma. Am J Pathol 2011, 179:1807-1814.
38. De Paiva C.S., Volpe E.A., Gandhi N.B., Zhang X., Zheng X., Pitcher J.D., et al. Disruption of TGF-beta signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One 2011, 6:e29017.
39. Moutsopoulos H.M., Hooks J.J., Chan C.C., Dalavanga Y.A., Skopouli F.N., Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis 1986, 45:677-683.
40. Lindahl G., Hedfors E., Klareskog L., Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren's syndrome. Clin Exp Immunol 1985, 61:475-482.
41. Manoussakis M.N., Dimitriou I.D., Kapsogeorgou E.K., Xanthou G., Paikos S., Polihronis M., et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum 1999, 42:229-239.
42. Legras F., Martin T., Knapp A.M., Pasquali J.L. Infiltrating T cells from patients with primary Sjogren's syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease. Eur J Immunol 1994, 24:181-185.
43. Ogawa N., Ping L., Zhenjun L., Takada Y., Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum 2002, 46:2730-2741.
44. Hasegawa H., Inoue A., Kohno M., Muraoka M., Miyazaki T., Terada M., et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum 2006, 54:1174-1183.
45. Kimura-Shimmyo A., Kashiwamura S., Ueda H., Ikeda T., Kanno S., Akira S., et al. Cytokine-induced injury of the lacrimal and salivary glands. J Immunother 2002, 25(Suppl. 1):S42-S51.
46. Kong L., Ogawa N., Nakabayashi T., Liu G.T., D'Souza E., McGuff H.S., et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 1997, 40:87-97.
47. Polihronis M., Tapinos N.I., Theocharis S.E., Economou A., Kittas C., Moutsopoulos H.M. Modes of epithelial cell death and repair in Sjogren's syndrome (SS). Clin Exp Immunol 1998, 114:485-490.
48. Gao J., Killedar S., Cornelius J.G., Nguyen C., Cha S., Peck A.B. Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun 2006, 26:90-103.
49. Meng W., Li Y., Xue E., Satoh M., Peck A.B., Cohen P.L., et al. B-Cell tolerance Defects in the B6.Aec1/2 mouse model of Sjogren's syndrome. J Clin Immunol 2012, 32:551-564.
50. Nguyen C.Q., Yin H., Lee B.H., Carcamo W.C., Chiorini J.A., Peck A.B. Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 2010, 12:R220.